Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase

Breast Cancer Research and Treatment

Volumn 130, Issue 2, 2011, Pages 387-398

  Pandey, Puspa R ^a   Okuda, Hiroshi ^a   Watabe, Misako ^a   Pai, Sudha K ^a   Liu, Wen ^a   Kobayashi, Aya ^a   Xing, Fei ^a   Fukuda, Koji ^a   Hirota, Shigeru ^b   Sugai, Tamotsu ^b   Wakabayashi, Go ^b   Koeda, Keisuke ^b   Kashiwaba, Masahiro ^b   Suzuki, Kazuyuki ^b   Chiba, Toshimi ^b   Endo, Masaki ^b   Fujioka, Tomoaki ^b   Tanji, Susumu ^b   Mo, Yin Yuan ^a   Cao, Deliang ^a   Wilber, Andrew C ^a   Watabe, Kounosuke ^a   more..

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Breast cancer; Fatty acid synthase; Lipogenesis; Stem like cells

Indexed keywords

2 FUROIC ACID DERIVATIVE; 5 TETRADECYLOXY 2 FUROIC ACID; FATTY ACID SYNTHASE; FUMONISIN B1; LIPID; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BNIP3 GENE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STEM CELL; CANCER STEM LIKE CELL; CANCER TISSUE; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DAPK2 GENE; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; FATTY ACID SYNTHASE GENE; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL PROLIFERATION; CELL SURVIVAL; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOGENESIS; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 82955178161     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1300-6     Document Type: Article

References (50)

1. Baur JA, Sinclair DA (2006) Therapeutic potential ofresveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506 (Pubitemid 44136961)
2. Pervaiz S (2003) Resveratrol: from grapevines to mammalian biology. FASEB J 17:1975-1985 (Pubitemid 37392442)
3. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397-1421
4. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C (2005) Resveratrol and breast cancer risk. Eur J Cancer Prev 14:139-142 (Pubitemid 40516975)
5. Das S, Khan N, Mukherjee S et al (2008) Redox regulation of resveratrol-mediated switching of death signal into survival sig-nal. Free Radic Biol Med 44:82-90 (Pubitemid 350138631)
6. Lin JK, Tsai SH (1999) Chemoprevention of cancer and cardio-vascular disease by resveratrol. Proc Natl Sci Counc Repub China B 23:99-106
7. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526
8. Szkudelska K, Nogowski L, Szkudelski T (2009) Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 13:17-24
9. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283 (Pubitemid 47575677)
10. Bishayee A (2009) Cancer prevention and treatment with resve-ratrol: from rodent studies to clinical trials. Cancer Prev Res 2:409-418
11. Jang M, Cai L, Udeani GO et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220 (Pubitemid 127696281)
12. Banerjee S, Bueso-Ramos C, Aggarwal BB (2002) Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcino-genesis in rats by resveratrol: role of nuclear factor-kappa B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62:4945-4954 (Pubitemid 34984418)
13. Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA (2007) Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28:1946-1953 (Pubitemid 47500607)
14. Kuhajda FP (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16:202-208 (Pubitemid 30114274)
15. Alo' PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U (1996) Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77: 474-482 (Pubitemid 26047568)
16. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP (1997) Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 3:2115-2120 (Pubitemid 27505140)
17. Rashid A, Pizer ES, Moga M et al (1997) Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150:201-208 (Pubitemid 27027110)
18. Swinnen JV, Roskams T, Joniau S et al (2002) Overexpression of fatty acid synthase is an early and common event in the devel-opment of prostate cancer. Int J Cancer 98:19-22 (Pubitemid 34113412)
19. Menendez JA, Lupu R (2007) Fatty acid synthase and the lipo-genic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763-777 (Pubitemid 47469806)
20. Migita T, Ruiz S, Fornari A et al (2009) Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 101:519-532
21. Bandyopadhyay S, Zhan R, Wang Y et al (2006) Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res 66:5934-5940 (Pubitemid 43927149)
22. Liu H, Liu Y, Zhang JT (2008) A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpres-sion-mediated palmitate overproduction. Mol Cancer Ther 7:263-270 (Pubitemid 351302520)
23. Furuta E, Pai SK, Zhan R et al (2008) Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regula-tory element binding protein-1. Cancer Res 68:1003-1011 (Pubitemid 351278386)
24. Furuta E, Okuda H, Kobayashi A, Watabe K (2010) Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta 1805:141-152
25. Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518-524 (Pubitemid 41112921)
26. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Pro-spective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983-3988 (Pubitemid 36418143)
27. Li C, Heidt DG, Dalerba P et al (2007) Identification of pan-creatic cancer stem cells. Cancer Res 67(3):1030-1037
28. Fillmore CM, Kuperwasser C (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to pheno-typically diverse progeny and survive chemotherapy. Breast Cancer Res 10(2):R2
29. Li C, Lee CJ, Simeone DM (2009) Identification of human pancreatic cancer stem cells. Methods Mol Biol 568:161-173
30. Huang TT, Lin HC, Chen CC et al (2010) Resveratrol induces apoptosis of human nasopharyngeal carcinoma cells via activa-tion of multiple apoptotic pathways. J Cell Physiol [Epub ahead of print]
31. Vanamala J, Reddivari L, Radhakrishnan S, Tarver C (2010) Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 10:238
32. Lee MH, Choi BY, Kundu JK et al (2009) Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res 69(18):7449
33. Boissy P, Andersen TL, Abdallah BM et al (2005) Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 65(21): 9943-9952 (Pubitemid 41541475)
34. Jiang H, Shang X, Wu H et al (2009) Resveratrol downregulates PI3K/Akt/m TOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol 8(1):25-33
35. Hwang J-T, Kwon DY, Park OJ, Kim (2008) Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr 2(4):323-326. doi:10.1007/s12263-007-0069-7 (Pubitemid 351447706)
36. Lin JN et al (2010) Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem 58(3):1584-1592
37. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H (2001) Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid car-cinoma A431 cells. Clin Cancer Res 7:1466-1473 (Pubitemid 32708704)
38. Bai Y, Mao QQ, Qin J et al (2010) Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 101:488-493
39. Gagliano N, Aldini G, Colombo G et al (2010) The potential of resveratrol against human gliomas. Anticancer Drugs 21:140-150
40. Wang J, He D, Zhang Q, Han Y, Jin S, Qi F (2009) Resveratrol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother Radiopharm 24:675-680
41. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hema-topoietic cell. Nat Med 3:730-737 (Pubitemid 27298715)
42. Hope KJ, Jin L, Dick JE (2004) Acute myeloid leukemia origi-nates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5:738-743 (Pubitemid 39023306)
43. Marx J (2007) Molecular biology. Cancer's perpetual source? Science 317:1029-1031 (Pubitemid 47330163)
44. Vitrac X, Desmoulière A, Brouillaud B et al (2003) Distribution of (14C)-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72:2219-2233 (Pubitemid 36292144)
45. Hamada J, Nakata D, Nakae D et al (2001) Increased oxidative DNA damage in mammary tumor cells by continuous epidermal growth factor stimulation. J Natl Cancer Inst 93:214-219 (Pubitemid 32166492)
46. Whyte L, Huang YY, Torres K, Mehta RG (2007) Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res 67:12007-12017
47. Zhang J (2006) Resveratrol inhibits insulin responses in a Sir T1-independent pathway. Biochem J 397:519-527 (Pubitemid 44187510)
48. Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA (2008) Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif 41:59-85 (Pubitemid 351147647)
49. Knowles LM, Yang C, Osterman A, Smith JW (2008) Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4. J Biol Chem 283:31378-31384
50. Bandyopadhyay S, Pai SK, Watabe M et al (2005) FAS expres-sion inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS si RNA to induce apoptosis. Oncogene 24:5389-5395 (Pubitemid 43080109)